Research Group
Cancer Biomarkers
Sponsor
M.D. Anderson Cancer Center
Status
Recruiting
NCT ID
NCT00539162
The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Intervention
Questionnaire
Condition
Ovarian Cancer
Investigators
Denise Nebgen, MD, PHD, Brian Slomovitz, MD, Georgia McCann, MD, Richard Moore, MD, Laura Holman, MD, Marian Williams-Brown, MD, Karen H. Lu, MD